Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback